Cargando…

Biotechnological challenges: The scope of genome editing

CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Natacha Salomé, Martínez, A Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brazilian Society of Assisted Reproduction 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863103/
https://www.ncbi.nlm.nih.gov/pubmed/32598833
http://dx.doi.org/10.5935/1518-0557.20200038
_version_ 1783647437019152384
author Lima, Natacha Salomé
Martínez, A Gustavo
author_facet Lima, Natacha Salomé
Martínez, A Gustavo
author_sort Lima, Natacha Salomé
collection PubMed
description CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human embryos has led to debates and interdisciplinary discussions. This brings multiple challenges for both scientists and those who must regulate the use of these techniques.
format Online
Article
Text
id pubmed-7863103
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Brazilian Society of Assisted Reproduction
record_format MEDLINE/PubMed
spelling pubmed-78631032021-02-10 Biotechnological challenges: The scope of genome editing Lima, Natacha Salomé Martínez, A Gustavo JBRA Assist Reprod Update Article CRISPR/Cas9 can be considered as the biotechnological breakthrough of the century. Genome editing technologies have developed in a vertiginous way. While the genome editing of species, including animals, plants and bacteria has become a commonly used method, the application of CRISPR-Cas9 in human embryos has led to debates and interdisciplinary discussions. This brings multiple challenges for both scientists and those who must regulate the use of these techniques. Brazilian Society of Assisted Reproduction 2021 /pmc/articles/PMC7863103/ /pubmed/32598833 http://dx.doi.org/10.5935/1518-0557.20200038 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Update Article
Lima, Natacha Salomé
Martínez, A Gustavo
Biotechnological challenges: The scope of genome editing
title Biotechnological challenges: The scope of genome editing
title_full Biotechnological challenges: The scope of genome editing
title_fullStr Biotechnological challenges: The scope of genome editing
title_full_unstemmed Biotechnological challenges: The scope of genome editing
title_short Biotechnological challenges: The scope of genome editing
title_sort biotechnological challenges: the scope of genome editing
topic Update Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863103/
https://www.ncbi.nlm.nih.gov/pubmed/32598833
http://dx.doi.org/10.5935/1518-0557.20200038
work_keys_str_mv AT limanatachasalome biotechnologicalchallengesthescopeofgenomeediting
AT martinezagustavo biotechnologicalchallengesthescopeofgenomeediting